Literature DB >> 18435961

Prognostic evaluation of ambulatory patients with advanced heart failure.

Wilfried Mullens1, Zuheir Abrahams, Hadi N Skouri, David O Taylor, Randall C Starling, Gary S Francis, James B Young, W H Wilson Tang.   

Abstract

Previous heart failure (HF) risk models have included clinical and noninvasive variables and have been derived largely from clinical trial databases or decompensated HF registries. The importance of hemodynamic assessment is less established, particularly in ambulatory patients with advanced HF. In this study, 513 consecutive ambulatory patients (mean age 54+/-11 years, mean left ventricular ejection fraction 20+/-9%) with symptomatic HF who underwent diagnostic right-sided cardiac catheterization as part of outpatient assessment from 2000 to 2005 were reviewed. After a total of 1,696 patient-years of follow-up, 139 (27%) patients had died and 116 (23%) had undergone cardiac transplantation. The 1- and 2-year overall survival rates (defined as freedom from death or cardiac transplantation) were 77% and 67%, respectively. Overall, 65% of patients had elevated intracardiac filling pressures, and 40% had cardiac indexes<2.2 L/min/m2. In multivariate analysis, mean pulmonary arterial pressure, cardiac index, and the severity of mitral regurgitation were the 3 strongest predictors of all-cause mortality and cardiac transplantation. Renal dysfunction was also an independent predictor of all-cause mortality. When a clinical model for Cox multivariate analysis of all-cause mortality was compared with a model that also included cardiac index and mean pulmonary arterial pressure, the chi-square score increased from 45 to 69 (p<0.0001). In conclusion, in ambulatory patients with advanced HF, hemodynamic and renal function assessments remain strong independent predictors of all-cause mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18435961     DOI: 10.1016/j.amjcard.2007.12.031

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  The natural history of preclinical diastolic dysfunction: a population-based study.

Authors:  Mark W Vogel; Joshua P Slusser; David O Hodge; Horng H Chen
Journal:  Circ Heart Fail       Date:  2012-01-25       Impact factor: 8.790

2.  Identifying important risk factors for survival in patient with systolic heart failure using random survival forests.

Authors:  Eileen Hsich; Eiran Z Gorodeski; Eugene H Blackstone; Hemant Ishwaran; Michael S Lauer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-11-23

3.  Prognostic role of cardiac power index in ambulatory patients with advanced heart failure.

Authors:  Justin L Grodin; Wilfried Mullens; Matthias Dupont; Yuping Wu; David O Taylor; Randall C Starling; W H Wilson Tang
Journal:  Eur J Heart Fail       Date:  2015-04-28       Impact factor: 15.534

4.  Threshold crossing of device-based intrathoracic impedance trends identifies relatively increased mortality risk.

Authors:  Wai Hong Wilson Tang; Eduardo N Warman; James W Johnson; Roy S Small; James Thomas Heywood
Journal:  Eur Heart J       Date:  2012-06-07       Impact factor: 29.983

5.  Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study.

Authors:  Martín J García-González; Manuel de Mora-Martín; Silvia López-Fernández; Javier López-Díaz; Manuel Martínez-Sellés; José Romero-García; Marco Cordero; Antonio Lara-Padrón; Francisco Marrero-Rodríguez; M del Mar García-Saiz; Ana Aldea-Perona
Journal:  Cardiovasc Drugs Ther       Date:  2013-12       Impact factor: 3.727

6.  Biological variation of the cardiac index in patients with stable chronic heart failure: inert gas rebreathing compared with impedance cardiography.

Authors:  Tobias Täger; Hanna Fröhlich; Jennifer Franke; Karen Slottje; Andrea Horsch; Dietmar Zdunek; Georg Hess; Andreas Dösch; Hugo A Katus; Frank H Wians; Lutz Frankenstein
Journal:  ESC Heart Fail       Date:  2015-06-15

7.  Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation - initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization.

Authors:  Yan Wen; Jonathan W Weinsaft; Thanh D Nguyen; Zhe Liu; Evelyn M Horn; Harsimran Singh; Jonathan Kochav; Sarah Eskreis-Winkler; Kofi Deh; Jiwon Kim; Martin R Prince; Yi Wang; Pascal Spincemaille
Journal:  J Cardiovasc Magn Reson       Date:  2019-11-18       Impact factor: 5.364

8.  Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study.

Authors:  Martín J García-González; Ana Aldea Perona; Antonio Lara Padron; José Luis Morales Rull; Manuel Martínez-Sellés; Manuel de Mora Martin; Javier López Díaz; Silvia López Fernandez; Pilar Ortiz Oficialdegui; Alejandro Jiménez Sosa
Journal:  ESC Heart Fail       Date:  2021-10-30

Review 9.  Quantitative susceptibility mapping (QSM) of the cardiovascular system: challenges and perspectives.

Authors:  Alberto Aimo; Li Huang; Andrew Tyler; Andrea Barison; Nicola Martini; Luigi F Saccaro; Sébastien Roujol; Pier-Giorgio Masci
Journal:  J Cardiovasc Magn Reson       Date:  2022-08-18       Impact factor: 6.903

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.